Cushman & Wakefield Reports Q4 Net Loss Due to Significant Greystone JV Impairment Amidst Record Revenue
Summary
Cushman & Wakefield reported a Q4 2025 net loss due to a $177 million impairment on a joint venture, despite achieving record revenue and strong adjusted earnings and cash flow for the quarter and full year.
Key Events
-
Q4 2025 Net Loss Reported
The company reported a net loss of $22.4 million ($0.10 diluted loss per share) for the fourth quarter of 2025, a significant decline from net income of $112.9 million in Q4 2024.
-
Material Greystone JV Impairment
The net loss was primarily attributed to a $177.0 million other-than-temporary impairment loss recognized on its equity method investment in Cushman Wakefield Greystone LLC.
-
Record Revenue and Strong Adjusted Growth
Cushman & Wakefield achieved record Q4 revenue of $2.9 billion (+11% year-over-year) and full-year revenue of $10.3 billion (+9% year-over-year). Adjusted EBITDA grew 7% in Q4 and 13% for the full year, with adjusted diluted EPS up 13% in Q4 and 34% for the full year.
-
Improved Cash Flow and Debt Reduction
Net cash provided by operating activities increased by $132.4 million to $340.4 million for 2025, and the company prepaid $300 million in principal outstanding under its term loans.
Analysis
Cushman & Wakefield Ltd. reported a net loss for the fourth quarter of 2025, primarily driven by a substantial $177.0 million non-cash impairment loss on its equity method investment in Cushman Wakefield Greystone LLC. This impairment significantly impacted GAAP results, leading to a net loss of $22.4 million for the quarter. Despite this, the company achieved its highest-ever fourth-quarter and full-year revenue, alongside robust growth in adjusted EBITDA and adjusted diluted EPS. The strong operational performance, improved cash flow, and debt reduction efforts indicate underlying business health, but the material impairment on the Greystone JV warrants investor attention regarding the performance and valuation of its equity investments.
At the time of this filing, CWK was trading at $12.25 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $7.64 to $17.40. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.